Australia markets open in 48 minutes
  • ALL ORDS

    7,325.80
    +8.30 (+0.11%)
     
  • AUD/USD

    0.7723
    -0.0017 (-0.22%)
     
  • ASX 200

    7,063.50
    +4.90 (+0.07%)
     
  • OIL

    62.82
    -0.31 (-0.49%)
     
  • GOLD

    1,776.30
    -3.90 (-0.22%)
     
  • BTC-AUD

    73,139.51
    -6,767.62 (-8.47%)
     
  • CMC Crypto 200

    1,398.97
    +7.26 (+0.52%)
     

Chronic Insomnia Epidemiology Forecast 2030 - ResearchAndMarkets.com

·5-min read

The "Chronic Insomnia - Epidemiology Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.

This 'Chronic Insomnia - Epidemiology Forecast - 2030' report delivers an in-depth understanding of Chronic Insomnia, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Chronic Insomnia Epidemiology

The Chronic Insomnia epidemiology division provides insights about the historical and current patient pool, along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends, along with assumptions undertaken.

Key Findings

The total prevalent cases of Chronic Insomnia patients are increasing in 7MM during the study period, i.e., 2018-2030.

The disease epidemiology covered in the report provides historical as well as forecasted Chronic Insomnia symptoms epidemiology segmented as the Prevalence of Insomnia, Diagnosed Prevalent Cases of Chronic Insomnia, Gender-specific cases of Chronic Insomnia, and Age-specific cases of Chronic Insomnia. The report includes the prevalent scenario of Chronic Insomnia symptoms in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.

Country-wise - Chronic Insomnia Epidemiology

The epidemiology segment also provides the Chronic Insomnia epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

The diagnosed prevalent cases of Chronic Insomnia associated in 7MM countries were 5,585,128 in 2020.

  • As per the estimates, the United States has the largest prevalent population of Chronic Insomnia.

  • Among the EU5 countries, France had the highest prevalent cases of Chronic Insomnia, followed by Germany. On the other hand, Spain had the lowest prevalent cases with 273,947 cases in 2020.

Scope of the Report

  • The Chronic Insomnia report covers a detailed overview explaining its causes, symptoms, and classification, pathophysiology, diagnosis, and treatment patterns.

  • The Chronic Insomnia Epidemiology Report and Model provide an overview of Chronic Insomnia's risk factors and global trends in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).

  • The report provides insight into Chronic Insomnia's historical and forecasted patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.

  • The report helps to recognize the growth opportunities in the 7MM concerning the patient population.

  • The report assesses the disease risk and burden and highlights the unmet needs of Chronic Insomnia.

  • The report provides the segmentation of the Chronic Insomnia epidemiology by prevalent cases of Insomnia in 7MM.

  • The report provides the Chronic Insomnia epidemiology segmentation by diagnosed prevalent cases of Chronic Insomnia in 7MM.

  • The report provides the Chronic Insomnia epidemiology segmentation by Gender-specific prevalent cases of Chronic Insomnia in 7MM.

  • The report provides the Chronic Insomnia epidemiology segmentation by Age-specific prevalent cases of Chronic Insomnia in 7MM.

Report Highlights

  • 10-year Forecast of Chronic Insomnia epidemiology

  • 7MM Coverage

  • Prevalent Cases of Insomnia

  • Total Diagnosed Prevalent Cases of Chronic Insomnia

  • Prevalent Cases according to segmentation: Gender-specific cases of Chronic Insomnia

  • Prevalent Cases according to segmentation: Age-specific cases of Chronic Insomnia

KOL Views

We interview KOLs, and SME's opinion through primary research to fill the data gaps and validate the secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM for the patient population about Chronic Insomnia?

  • What are the key findings of the Chronic Insomnia epidemiology across 7MM, and which country will have the highest number of patients during the study period (2018-2030)?

  • What would be the total number of Chronic Insomnia patients across the 7MM during the study period (2018-2030)?

  • Among the EU5 countries, which country will have the highest number of patients during the study period (2018-2030)?

  • At what CAGR the patient population is expected to grow in 7MM during the study period (2018-2030)?

  • What are the disease risk, burden, and unmet needs of Chronic Insomnia?

  • What are the currently available treatments for Chronic Insomnia?

Key Assessments

  • Patient Segmentation

  • Disease Risk and Burden

  • Risk of disease by the segmentation

  • Factors driving growth in a specific patient population

Geographies Covered

  • The United States

  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)

  • Japan

Key Topics Covered:

1 Key Insights

2 Report Introduction

3 Chronic Insomnia Market Overview at a Glance

3.1 Market Share (%) Distribution of Chronic Insomnia in 2018

3.2 Market Share (%) Distribution of Chronic Insomnia in 2030

4 Executive Summary of Chronic Insomnia

5 Disease Background and Overview

5.1 Introduction

5.2 Pathophysiology

5.3 Mechanism of Sleep and Insomnia

5.4 Genetics of Insomnia

5.5 Comorbidities of Chronic Insomnia

5.6 Risk Factors

5.7 Diagnosis

5.8 Differential Diagnosis

5.9 Diagnosis Guidelines

5.1 Treatment

6 Epidemiology and Patient Population

6.1 Key Findings

6.2 7MM Total Diagnosed Prevalent Population of Chronic Insomnia

6.3 Epidemiology of Chronic Insomnia

6.4 The United States

6.4.1 Prevalence of Insomnia in the United States

6.4.2 Diagnosed Prevalent Cases of Chronic Insomnia in the United States

6.4.3 Gender-specific cases of Chronic Insomnia in the United States

6.4.4 Age-specific Cases of Chronic Insomnia in the United States

6.5 EU5

6.5.1 Germany

6.5.2 France

6.5.3 Italy

6.5.4 Spain

6.5.5 United Kingdom

6.6 Japan

7 KOL Views

8 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/r6ipzc

View source version on businesswire.com: https://www.businesswire.com/news/home/20210302005527/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900